ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lilly stops promoting cancer drug after shock trial failure pharmaphorum
January 22, 2019Shares in Eli Lilly were down in early trading after the US drugmaker said its cancer drug Lartruvo failed to meet main survival goals in a late stage trial, prompting the company to stop promoting the already-marketed medicine.
Pharma Sources Insight July 2025
